Vagal Stimulation Ameliorates Non-Alcoholic Fatty Liver Disease in Rats

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Dec 23

PMID 38137476

Authors

Hany A Elkattawy

Samar Mortada Mahmoud

Ahmed El-Sayed Hassan

Ahmed Behiry

Hasnaa Ali Ebrahim

Ateya Megahed Ibrahim

Donia Elsaid Fathi Zaghamir

Mohamed El-Sherbiny

Sherein F El-Sayed

Affiliations

Soon will be listed here.

Abstract

Background: The harmful consequences of non-alcoholic fatty liver disease (NAFLD) are posing an increasing threat to public health as the incidence of diabetes and obesity increases globally. A non-invasive treatment with a range of autonomic and metabolic benefits is transcutaneous vagus nerve stimulation (tVNS).

Aim Of The Study: To investigate the possible preventive impacts of VNS against adult rats' NAFLD caused by a high-fat diet (HFD) and to clarify the underlying mechanisms.

Methods: A total of thirty-two adult male rats were split into two groups: the HFD-induced NAFLD group ( = 24) and the control normal group ( = 8). The obesogenic diet was maintained for 12 weeks to induce hepatic steatosis. The HFD-induced NAFLD group ( = 24) was separated into three groups: the group without treatment ( = 8), the group with sham stimulation ( = 8), and the group with VNS treatment ( = 8). VNS was delivered for 30 min per day for 6 weeks after the establishment of NAFLD using a digital TENS device. The subsequent assessments included hepatic triglyceride, cholesterol content, serum lipid profile, and liver function testing. In this context, inflammatory biomarkers (TNF-α, IL-6) and hepatic oxidative stress (MDA, SOD, and GPx) were also assessed. To clarify the possible mechanisms behind the protective benefits of VNS, additional histological inspection and immunohistochemistry analysis of TNF-α and Caspase-3 were performed.

Results: In the NAFLD-affected obese rats, VNS markedly decreased the rats' body mass index (BMI) and abdominal circumference (AC). Liver function markers (albumin, ALT, and AST) and the serum lipid profile-which included a notable decrease in the amounts of hepatic triglycerides and cholesterol-were both markedly improved. Additionally, oxidative stress and inflammatory indicators showed a considerable decline with VNS. Notably, the liver tissues examined by histopathologists revealed that there is evidence of the protective impact of VNS on the oxidative and inflammatory states linked to HFD-induced NAFLD while maintaining the architectural and functional condition of the liver.

Conclusions: Our findings suggest that VNS may represent a promising therapeutic candidate for managing NAFLD induced by obesity. It can be considered to be an effective adjuvant physiological intervention for the obese population with NAFLD to spare the liver against obesity-induced deleterious injury.

References

Clancy J, Mary D, Witte K, Greenwood J, Deuchars S, Deuchars J . Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 2014; 7(6):871-7. DOI: 10.1016/j.brs.2014.07.031. View

Cohen M, Georgievskaya Z . Histopathology of the stimulated Vagus nerve: primum non nocere. Heart Fail Rev. 2010; 16(2):163-9. DOI: 10.1007/s10741-010-9182-6. View

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Jiang Y, Li L, Liu B, Zhang Y, Chen Q, Li C . PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats. Med Sci Monit. 2015; 21:268-75. PMC: 4310716. DOI: 10.12659/MSM.891407. View

Verdelho Machado M, Diehl A . Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology. 2016; 150(8):1769-77. PMC: 4887389. DOI: 10.1053/j.gastro.2016.02.066. View

Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W . Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022; 22(1):63. PMC: 8919523. DOI: 10.1186/s12902-022-00980-1. View

Bonaz B, Sinniger V, Pellissier S . Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases. Front Neurosci. 2021; 15:650971. PMC: 8019822. DOI: 10.3389/fnins.2021.650971. View

Luo B, Wu Y, Liu S, Li X, Zhu H, Zhang L . Vagus nerve stimulation optimized cardiomyocyte phenotype, sarcomere organization and energy metabolism in infarcted heart through FoxO3A-VEGF signaling. Cell Death Dis. 2020; 11(11):971. PMC: 7665220. DOI: 10.1038/s41419-020-03142-0. View

Wang Z, Yu L, Wang S, Huang B, Liao K, Saren G . Chronic intermittent low-level transcutaneous electrical stimulation of auricular branch of vagus nerve improves left ventricular remodeling in conscious dogs with healed myocardial infarction. Circ Heart Fail. 2014; 7(6):1014-21. DOI: 10.1161/CIRCHEARTFAILURE.114.001564. View

10.

Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M . Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23(1):57-63. DOI: 10.2337/diacare.23.1.57. View

11.

Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View

12.

FOSTER L, Dunn R . Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem. 1973; 19(3):338-40. View

13.

Samniang B, Shinlapawittayatorn K, Chunchai T, Pongkan W, Kumfu S, Chattipakorn S . Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats. Sci Rep. 2016; 6:19749. PMC: 4735283. DOI: 10.1038/srep19749. View

14.

de Lartigue G . Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol. 2016; 594(20):5791-5815. PMC: 5063945. DOI: 10.1113/JP271538. View

15.

Elks C, Francis J . Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep. 2010; 12(2):99-104. DOI: 10.1007/s11906-010-0096-4. View

16.

Sanyal A . Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2019; 16(6):377-386. DOI: 10.1038/s41575-019-0144-8. View

17.

Li H, Zhang J, Xu C, Tang Q, Shen W, Zhou J . Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet--induced obese rats. Nutrition. 2015; 31(11-12):1416-22. DOI: 10.1016/j.nut.2015.05.007. View

18.

George M, Sackeim H, Rush A, Marangell L, Nahas Z, Husain M . Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000; 47(4):287-95. DOI: 10.1016/s0006-3223(99)00308-x. View

19.

Elkattawy H, Elsherbini D, Ebrahim H, Abdullah D, Al-Zahaby S, Noser Y . Rho-kinase inhibition ameliorates non-alcoholic fatty liver disease in type 2 diabetic rats. Physiol Res. 2022; 71(5):615-630. PMC: 9841803. DOI: 10.33549/physiolres.934869. View

20.

Liu C, L Bookout A, Lee S, Sun K, Jia L, Lee C . PPARγ in vagal neurons regulates high-fat diet induced thermogenesis. Cell Metab. 2014; 19(4):722-30. PMC: 4046333. DOI: 10.1016/j.cmet.2014.01.021. View